Rafael Fonseca, MD from the Mayo Clinic, Scottsdale, AZ discusses the cost of drugs in multiple myeloma (MM) and the debate around the issue. According to Prof Fonesca, the costs associated with drug development have to be accounted for and a more data-driven and free market approach are needed to solve the issue of drug affordability.
Recorded at the American Society of Oncology (ASCO) 2016 Annual Meeting held in Chicago, IL.
Advertisement
Annual Meeting 2016: A free market and data-driven approach to solve the issue of drug cost
By Editor